Home・Stock List・Schrodinger Inc

Schrodinger Inc

Open

SectorHealthcare

17.72 7.79

Buy Sell

Overview

Share price change

24h

Current

Min

16.3

Max

18.35

Key metrics
By Trading Economics
Income	-196M -60M
Sales	-29M 59M
EPS	-0.62
Profit margin	-102.456
Employees	850
EBITDA	-94M -58M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+23.48% upside

Dividends
By Acuity
Next Earnings	4 Nov 2026

Market Stats
By TradingEconomics
Market Cap	178M 1.1B
Previous open	9.93
Previous close	17.72

News Sentiment

By Acuity

91%

12 / 340 Healthcare

Schrodinger Inc Chart

Past performance is not a reliable indicator of future results.

Related News

5 Aug 2026, 23:01 UTC

News

Schrodinger Inc reported second-quarter adjusted EPS of $0.08, surpassing estimates. Revenue reached $58.889 million, leading to higher after-market trading.

3 Aug 2026, 19:51 UTC

Correlated Moves

Schrodinger Inc shares are higher, reflecting broader market gains amid a drop in oil prices and positive sentiment in the technology sector.

31 Jul 2026, 19:46 UTC

Correlated Moves

Schrodinger Inc shares are lower amid declining first-quarter results and broader market pressure, despite an earlier rebound from session lows.

30 Jul 2026, 18:46 UTC

Correlated Moves

Schrodinger Inc. advanced during Thursday's session, supported by broader market gains despite earlier pulling back from a session high.

29 Jul 2026, 20:51 UTC

Correlated Moves

Schrodinger Inc shares are lower in after-market trading, influenced by a broader market downturn and rising crude oil prices amid geopolitical tensions.

28 Jul 2026, 23:01 UTC

Schrodinger Inc. shares declined in after-market trading, remaining below their 20-day moving average amid broader market strength and pressure on technology stocks.

27 Jul 2026, 22:51 UTC

Schrodinger Inc. shares are higher in after-market trading, despite remaining below their 20-day moving average amid broader market dynamics and falling crude oil prices.

24 Jul 2026, 15:11 UTC

Schrodinger Inc shares are declining today, continuing a downward trend since Thursday's close. A pullback in crude oil prices may be affecting investor sentiment.

20 Jul 2026, 15:12 UTC

Correlated Moves

Schrodinger Inc. shares are lower amid a decline in the ARK Genomic Revolution ETF and broader market pressures, despite a slight rebound earlier in the session.

Peer Comparison

Price change

Schrodinger Inc Forecast

Price Target

By TipRanks

23.48% upside

12 Months Forecast

Average 20.25 USD 23.48%

High 24 USD

Low 17 USD

Based on 6 Wall Street analysts offering 12 month price targets forSchrodinger Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

Buy

Hold

Sell

Based on 6 analysts giving stock ratings to Schrodinger Inc - Dist in the past 3 months.

Sentiment

By Acuity

12 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.